Sunday, March 7, 2021

Which startups will present at MedCity INVEST Precision Medicine Pitch Perfect?

Finish line ahead
The MedCity INVEST Precision Medicine healthcare conference on December 9-11 will draw healthcare and life science executives as we spotlight progress in the development of diagnostics, clinical trial innovation, AI in drug development, and reimbursement models for cell and gene therapy. But at the heart of the conference will be startups in health...

Northwell, Conversa Health join forces to provide employers with Covid-19 screening tool

Northwell Direct, a subsidiary of New Hyde Park, New York-based Northwell Health, has partnered with virtual care company Conversa Health to offer employers a Covid-19 screening tool for their employees. Northwell Direct was developed over the last two years and established earlier this year. It was created to bring clinical services and other capabilities...

Reimagining Population Health Management: Can Genomics Evolve our Sick Care System into a True Healthcare System

Imagine if our healthcare system could actually prevent us from becoming patients in the first place. In today’s healthcare, we use only 10% of the data that predicts health outcomes. Genetic information has the potential to radically improve our predictive power and to help risk-stratify the patients at highest and lowest risk of common...

Digital pathology startup Proscia lands $23M to advance software platform

A digital pathology company has raised $23 million in Series B funding as it seeks to push its cancer-detecting software into new markets.Philadelphia-based Proscia has made inroads into the research and biopharma markets since the company was founded in 2014, said David West, Proscia’s CEO and a co-founder. The company is now looking...

Hims & Hers to go public through blank-check company

Direct-to-consumer health company Hims Inc. said it plans to go public through a blank-check company. The San Francisco-based startup confirmed ongoing reports that it was in talks to sell to a special-purpose acquisition company. The men’s health company first made its foray with cheeky subway ads for hair loss and erectile dysfunction medications. Its...

Why hydroxychloroquine’s appeal endures despite evidence it doesn’t work for Covid-19

“Any study that says hydroxychloroquine doesn’t work is fake science.” Those were the words of Dr. Stella Immanuel, a physician who claimed to have successfully treated 350 Covid-19 patients with hydroxychloroquine, azithromycin and zinc. Immanuel appeared with a Tea Party-linked group calling itself America’s Frontline Doctors in a July 27 video of a press...

PointClickCare to acquire Collective Medical in $500M+ deal

PointClickCare Technologies is planning to acquire care coordination platform Collective Medical. The deal, which is expected to close by the end of December, is valued between $500 million and $1 billion, PointClickCare Founder and CEO Mike Wessinger said in an email. PointClickCare offers cloud-based software to long-term and post-acute care providers to help them...

The e-doctor will see you now

The term ‘doctor in a box’ – once used as a derisive term for physicians that provide primary health care at an hourly rate in unaffiliated ambulatory care clinics – has taken on a very different meaning. There, for the past seven years, it has been used to describe several formats of telemedicine...

FDA issues surprise rejection of Gilead, Galapagos rheumatoid arthritis drug

Buildings 1 and 2 of the FDA campus A drug for rheumatoid arthritis that was seen as potentially a significant driver of growth has been turned down by the Food and Drug Administration, dealing a blow to the companies that developed it. Foster City, California-based Gilead Sciences said in an after-hours announcement Tuesday that...

Cue Health gets $481M to expand production of rapid coronavirus test

Cue Health received an emergency use authorization for its rapid molecular coronavirus test. The company is developing a portable testing platform that sends results to users’ smartphones. Photo credit: Cue Health A San Diego-based startup won a $481 million contract from the Department of Health and Human Services (HHS) and the Department of Defense...
0FansLike
0FollowersFollow
- Advertisement -

Must Read